Watabe et al. conducted a study in which biochemical prostate cancer recurrence was defined as a continuous increase in PSA level after radical prostatectomy or radiation therapy without any apparent recurrent lesions on conventional diagnostic imaging (CT and bone scintigraphy). The gene discussed is KLK3; the disease is Familial prostate cancer.